Copyright
©The Author(s) 2019.
World J Gastrointest Pharmacol Ther. Mar 7, 2019; 10(2): 35-49
Published online Mar 7, 2019. doi: 10.4292/wjgpt.v10.i2.35
Published online Mar 7, 2019. doi: 10.4292/wjgpt.v10.i2.35
Authors | Study design | Sample | Objectives | Results |
Cameron DJ, 1991[19] | Observational, prospective | 56 children and adolescents with CD | Evaluate the results of systematic upper and lower GI endoscopy in 56 patients with newly diagnosed CD | UGI symptoms 25% |
Macroscopic findings: 71% | ||||
H. pylori infection: All the patients were negative | ||||
Epithelioid granuloma: 27% | ||||
Prevalence: 53.6% | ||||
Halme et al, 1996[13] | Observational, cross sectional | 62 adults with CD | Determine the prevalence of gastritis and H pylori infection in patient with CD | Macroscopic findings : 53.2% |
H. pylori infection: 9.7% | ||||
Microgranulomas: 6.4% | ||||
Prevalence(H. pylori negative chronic gastritis): 34% | ||||
Abdullah et al, 2002[17] | Observational, retrospective | 111 children (81 CD and 34 UC) | Assess the role of esophagogastroduodenoscopy in the evaluation of children with suspected inflammatory bowel disease | Macroscopic findings(CD): 64%(52/81) |
Microscopic findings(CD): 81.6%(66/81) | ||||
H. pylori infection: 1.2% | ||||
Epithelioid granuloma: 28.4% | ||||
Macroscopic finding(UC): 50% | ||||
Microscopic finding(UC): 70.6% | ||||
Granuloma: absent | ||||
Crocco et al, 2012[18] | Observational, prospective | 45 children and adolescents newly diagnosed with CD | Evaluate the prevalence and clinical implications of the upper gastrointestinal localization in pediatric patients affected by CD | UGI symptoms 54% |
Macroscopic findings: 38%(erosions and ulcers), 42.2%(edema and redness) | ||||
H. pylori infection: 4.4% | ||||
Epithelioid granuloma: 27% | ||||
Annunziata et al, 2012[14] | Observational, prospective | 119 adults with CD(45 newly diagnosed and 74 previous diagnosis) | Evaluate the prevalence of upper GI involvement in consecutive patients with known or suspected CD, irrespective of upper tract symptoms | UGI symptoms: 37% |
Macroscopic findings: 48.7% | ||||
Microscopic findings: 59.7% | ||||
H. pylori infection: 8.4% | ||||
Epithelioid granuloma: 52.6% | ||||
Prevalence (macroscopic + microscopic findings): 16%(19/119) | ||||
Sakuraba et al, 2014[15] | Observational, retrospective | 138 adults with CD | Define endoscopic UGI lesions and assess their prevalence in a cohort of CD patients | UGI symptoms: 25.4% |
H. pylori infection: 10.8%(4/37) | ||||
Non caseating granuloma: 10.9% | ||||
Prevalence (macroscopic specific findings): 51.3% | ||||
Horjus Talabur Horje et al, 2016[16] | Observational, cross sectional | 152 adults with CD newly diagnosed | Prospectively evaluate the prevalence of UGI involvement in a consecutive series of newly diagnosed, treatment-naive adult patients with IBD irrespective of upper gastrointestinal tract symptoms | UGI symptoms 21% |
Macroscopic findings: 55% | ||||
Microscopic findings: 71% | ||||
H. pylori infection: 6% | ||||
Epithelioid granuloma: 31% | ||||
Prevalence: 41% | ||||
Park et al, 2017[20] | Observational, retrospective | 52 pediatrics patients with CD | Evaluate the prevalence of upper GI involvement and identify the clinical features of Korean children with CD symptoms | UGI symptoms: 30.8% |
Macroscopic findings: gastric ulcers (19.2%), duodenal ulcers (15.4%), gastric erosions (17.3%), duodenal erosions (5.8%) | ||||
Microscopic findings: chronic inflammation (75%) | ||||
H. pylori infection: 5.8% | ||||
Granuloma: 9.6% | ||||
Prevalence: 50% |
- Citation: Pimentel AM, Rocha R, Santana GO. Crohn’s disease of esophagus, stomach and duodenum. World J Gastrointest Pharmacol Ther 2019; 10(2): 35-49
- URL: https://www.wjgnet.com/2150-5349/full/v10/i2/35.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v10.i2.35